netFormulary NHS
Nottinghamshire Area Prescribing Committee
Joint Formulary
 Search
 Results

Looking for Dasatinib found 13 matches

Open monograph to display formulary status BNF Category
  Restricted Drug Dasatinib  (Sprycel) Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
  Restricted Drug Bosutinib  (Bosulif) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
  Restricted Drug Imatinib Malignant disease and immunosuppression - Protein kinase inhibitors - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA425: Dasatinib, nilotinib and high dose imatinib for CML (08.01.05)
link in drug section NICE TA425:Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA425:Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA425:Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA426: Dasatinib, nilotinib and imatinib for first line treatment of CML (08.01.05)
link in drug section NICE TA426:Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA426:Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia (08.01.05)
link in drug section NICE TA426:Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia (08.01.05)
link in drug section SFHT Dasatinib regimen in CML (08.01.05)
link in drug section SFHT Dasatinib regimen in Spirit trial (08.01.05)


 

netFormulary